SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-076261
Filing Date
2024-06-21
Accepted
2024-06-21 16:20:04
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3917
  Complete submission text file 0000950170-24-076261.txt   5370
Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK D CAMBRIDGE MA 02140
Business Address
Werner Michelle C (Reporting) CIK: 0001991154 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40657 | Film No.: 241060673